partner representatives
The AIBL study draws together experts in neuroimaging, biomarkers, neuropsychology, and lifestyle interventions.
lead scientists
Prof. David Ames
The study is lead by Prof. David Ames BA, MD, FRCPsych, FRANZCP, professor of Ageing and Health at the University of
Melbourne and Director of The National Ageing Research Institute (NARI).
Prof. Aimes holds the University of Melbourne's Foundation Chair of Psychiatry of Old Age at St. George's
Hospital Kew where he is also Director of the Aged Psychiatry Service. He is a member of the Medical &
Scientific Advisory Panel of Alzheimer's Disease International and has been Editor of the Peer Reviewed
Journal International Psychogeriatrics since January 2003. His main research interests are new drug treatments
for Alzheimer's disease and the care of the depressed elderly.
Dr. Kathryn Ellis
Dr. Kathryn Ellis BAppSc (Hons), PhD, graduated with a bachelor of applied science with first class honours
in psychology and psychophysiology in 2000. She was awarded one of four prestigious Swinburne University Chancellor's
Research Scholarships in 2001 to undertake her PhD in behavioural neurosciences, which involved a year placement
at Imperial College of London conducting PET neuroimaging and studies of cognition. Kathryn currently holds a research
fellow position at the University of Melbourne and her main roles include national management of the AIBL study and
management of the Melbourne node of Dementia Collaborative Research Centre. Dr. Ellis, Prof. Paul Maruff (Chief Science Officer,
Cogstate Ltd, and Centre for Neuroscience, University of Melbourne), Associate Prof. Greg Savage (Macquarie Centre for
Cognitive Science, NSW) and Dr. Jonathan Foster (Senior Fellow in Cognitive Neuroscience, Edith Cowan University)
lead the neuropsychological testing of the cohort to classify participants and monitor their condition.
Prof. Ralph Martins
Prof. Ralph Martins BSC (Hons) PhD holds the Inaugural Chair, Ageing and Alzheimer's Disease, Edith Cowan University, Western Australia, and also heads the Edith Cowan University's Centre for Excellence in Alzheimer's Disease Research and Care. Prof Martins' research isolated and characterized the protein components of the amyloid deposits characteristic of Alzheimer's disease. Together with Prof. Ashley Bush (Federation Fellow at the MHRI) who is internationally renowned for seminal discoveries on the impact of metal and oxidative biology on neurodegenerative disorders, Prof. Martins leads the diagnostics and biomarkers program aimed at early stage identification and assessing effectiveness of interventions.
Prof. Colin Masters
Prof. Colin Masters, Emeritus Professor of Pathology, University of Melbourne and Director of
The Mental Health Research Institute of Victoria (MHRI) has major input into the biomarkers program
based on his discovery of the brain amyloid protein and extensive international network. Prof.
Masters is a world leader in research into Alzheimer's disease and viral infections of the brain.
He was the recipient of a 2002 Citation Laureate Award for his contribution to research. He also was
awarded Australia's Mayne Florey Medal in 2002 and the King Faisal Award in 1997. Prof. Masters has held
many senior scientific positions and is a Professor of Pathology at the University of Melbourne. He is
also Chief of Neuropathology of the Mental Health Research Institute of Victoria, Consultant in
pathology at the Royal Melbourne Hospital and a scientific advisor to Neuroscience Australia.
Dr. Andrew Milner
Dr. Andrew Milner is CEO of Neurosciences Victoria Ltd. and Neurosciences Australia Ltd. He did his PhD at the Australian National University and has previously worked in commercial organisations developing, manufacturing and marketing products for human and animal health. His previous positions were in Mimotopes, AstraZeneca, Zeneca, Kendle, and Daratech.
Prof. Chris Rowe
Christopher Rowe FRACP MD is Director of the Department of Nuclear Medicine and Centre for PET and a consultant neurologist to the Memory Disorders Clinic at the Austin Hospital, Melbourne. He has published extensively on SPECT in epilepsy and beta-amyloid imaging in Alzheimer's disease. Prof. Rowe and Associate Professor Nat Lenzo (Fremantle Hospital and Edith Cowan University) apply state-of-the-art neuroimaging technology to develop and confirm new diagnostic tests and biomarkers.
Dr. Cassandra Szoeke
Dr. Cassandra Szoeke brings together management skills with a scientific background in genetics,
pharmacology, neurology and neurodegenerative disease. Cassandra is responsible for the strategic
development, science planning and project portfolio management of neurodegenerative disease research
activities across the CSIRO Preventative Health Flagship. Prior to joining the CSIRO, Dr. Szoeke was
working full time in clinical neurology with an academic appointment at the University of Melbourne.
She continues to maintain her clinical practise as a neurologist and supervision of tertiary students
with a part time academic appointment.
study research team
- Osca Acosta
- David Ames
- Jennifer Ames
- Manoj Agarwal
- Alex Bahar-Fuchs
- David Baxendale
- Kiara Bechta-Metti
- Carlita Bevage
- Lindsay Bevege
- Pierrick Bourgeat
- Belinda Brown
- Ashley Bush
- Roger Clarnette
- Tiffany Cowie
- Kathleen Crowley
- Andrew Currie
- David Darby
- Daniela De Fazio
- Denise El- Sheikh
- Kathryn Ellis
- Kerryn Dickinson
- Maree Farrow
- Noel Faux
- Jonathan Foster
- Jurgen Fripp
- Christopher Fowler
- Veer Gupta
- Peter Hudson
- Gareth Jones
- Jane Khoo
- Asawari Killedar
- Neil Killeen
- Tae Wan Kim
- Eleftheria Kotsopoulos
- Rebecca Lachovitski
- Nicola Lautenschlager
- Nat Lenzo
- Qiao-Xin Li
- Xiao Liang
- Kathleen Lucas
- James Lui
- Georgia Martins
- Ralph Martins
- Paul Maruff
- Colin Masters
- Andrew Milner
- Claire Montague
- Lynette Moore
- Audrey Muir
- Christopher O'Halloran
- Graeme O'Keefe
- Anita Panayiotou
- Athena Paton
- Jacqui Paton
- Jeremiah Peiffer
- Svetlana Pejoska
- Kelly Pertile
- Kerryn Pike
- Lorien Porter
- Roger Price
- Parnesh Raniga
- Glenn Rees
- Alan Rembach
- Miroslava Rimajova
- Peter Robbins
- Elizabeth Ronsisvalle
- Rebecca Rumble
- Mark Rodrigues
- Christopher Rowe
- Olivier Salvado
- Jack Sach
- Mathew Samuel
- Greg Savage
- Gobhathai Sittironnarit
- Cassandra Szoeke
- Kevin Taddei
- Tania Taddei
- Darshan Trivedi
- Brett Trounson
- Marinos Tsikkos
- Victor Villemagne
- Stacey Walker
- Vanessa Ward
- Michael Woodward
- Olga Yastrubetskaya
quick links
- Prof. David Ames
- Dr. Kathryn Ellis
- Prof. Ralph Martins
- Prof. Colin Masters
- Dr. Andrew Milner
- Prof. Chris Rowe
- Dr. Cassandra Szoeke
- study research team
partner organisations
publications
-
AIBL volunteers function presentation [PDF:530kb]
-
The Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing (AIBL) methodology and baseline
characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease. [PDF:224kb]
In Press. International Psychogeriatrics, First View article. Published online by Cambridge University Press 27 May 2009
doi: 10.1017/S1041610209009405 - P1-238: The Australian biomarker, imaging and lifestyle study: Preliminary PiB results Alzheimer's and Dementia, Volume 4, Issue 4, Supplement 1, July 2008, Page T283 doi:10.1016/j.jalz.2008.05.827
- IC-03-03: The Australian Biomarker, Imaging and Lifestyle Study: Preliminary PIB results Alzheimer's and Dementia, Volume 4, Issue 4, Supplement 1, July 2008, Page T7 doi:10.1016/j.jalz.2008.05.008
- Discovering the Early Biomarkers of Alzheimer's Disease: Neuropsychological Findings from the Longitudinal AIBL Flagship Study of Ageing [Abstract]. Brain Impairment, 9, 2008, 64-65.